Abstract. 1-(2-(piperidin-1-yl)ethyl)-1H-pyrrole-2-carbaldehyde 4a-b is a new aqueous solubility aldehyde as an important intermediates of small molecule anticancer drugs. In this work, a rapid synthetic method for target compounds 4a-b was established. The compound 4a-b was synthesized from the commercially available pyrrole through three steps including acylation and two steps nucleophilic substitution. The structure was confirmed by MS and 1 HNMR. Furthermore, the synthetic method was optimized. The total yield of the three steps was 65%.
Introduction
1H-pyrrole-2-carbaldehyde (1) is a key intermediate and has a wide range of applications in the pharmaceutical and chemical fields. 2-((1H-pyrrol-2-yl) methylene) hydrazine-1-carbothioamide (2) was designed and synthesized basing on 1H-pyrrole-2-carbaldehyde [1] [2] [3] . 2-((1-methyl-5-(2-(trifluoromethyl)phenyl)-1H-pyrrol-2-yl)methylene)hydrazine-1-carboximidamid e(3) was synthesized according to 1-methyl-1H-pyrrole-2-carbaldehyde by Gilles Gaubert, Fabio Bertozzi et al [4] [5] [6] . Wei Gan, Patrick J. Moon [7] [8] [9] 
Materials and Methods
All melting points were obtained on a Büchi Melting Point B-540 apparatus and were uncorrected. NMR spectra were performed using Bruker 400 MHz spectrometers with TMS 210 as an internal standard. Mass spectra (MS) were taken in ESI mode on Agilent 1100 LC-MS. All the materials were obtained from commercial suppliers and used without purification, unless otherwise specified. Yields were not optimized. TLC analysis was carried out on silica gel plates GF254.
Synthesis of Compounds
The structures and the synthetic route were shown in Scheme 1. . N,N-dimethylformamide (2.15 g, 30.0 mmol) in an ice bath was slowly treated with POCl 3 (3.38 g, 30.0 mmol). The ice bath was removed, and the mixture was stirred for 5 min. The ice bath was replaced, and anhydrous 1,1-dichloroethane (6.8 mL) was added, followed by a solution of pyrrole (1) (1.25 g, 18.4 mmol) in 1,1-dichloroethane (6.8 mL) over 30 min. The mixture was refluxed for 15 min and then cooled to room temperature. A saturated aqueous NaOAc solution (6.9 g of NaOAc in 15 mL of deionized water) was added, and the mixture was refluxed for 15 min. The mixture was cooled to room temperature and then was diluted with diethyl ether. The mixture was washed with saturated aqueous NaHCO 3 solution. The organic layer was dried (Na 2 SO 4 ) and concentrated to yield a brown solid (2. . 1H-pyrrole-2-carbaldehyde (2) was dissolved in DMSO (10mL). NaH (2.53g 60%, 6.0mmol) was slowly added to the solution and stirred for 30 min at room temperature. Then 1-chloro-2-bromoethane 8 g (42.5mmol) was added dropwise and refluxed for 1 h at 110 ℃. The reaction was monitored by thin-layer chromatography (TLC). The reaction solution was added to saturated NaCl and extracted with ethyl acetate. The organic layer was dried over anhydrous Na 2 SO 4 and concentrated under a reduced pressure to afford 1-(2-bromoethyl)-1H-pyrrole-2-carbaldehyde (3) as yellow liquid(3.53 g, 96%).
Preparation for 1-(2-(piperidin-1-yl) ethyl)-1H-pyrrole-2-carbaldehyde (4).
A mixture of 1-(2-bromoethyl)-1H-pyrrole-2-carbaldehyde (3.53 g, 17.7mmol), Piperidine (3.0 g, 35.4mmol) and DMF (20mL) was heated and stirred for 24 h at 125 ℃, and the reaction was monitored by TLC. The mixture was added to saturated NaCl, extracted with ethyl acetate. The combined organic layer was dried over anhydrous Na 2 SO 4 and was concentrated under a reduced pressure to obtain 1-(2-(piperidin-1-yl)ethyl)-1H-pyrrole-2-carbaldehyde (4) as yellow liquid (3.0g, 85%) . 
Conclusions
In conclusion, 4a-b were synthesized from the commercially available pyrrole through three steps including acylation and nucleophilic substitution. Due to optimization of the synthesis conditions of the target compound 4a-b, the purity of the product was much more higher. Its structure was confirmed by 1HNMR spectrum.
